| |
| |
|
| Insider
Information: |
Gadicke Ansbert |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
30,197 |
|
|
Indirect Shares
|
56,162,356 |
|
|
| Direct
Value |
$24,158 |
|
|
|
Indirect Value
|
$175,564,239 |
|
|
| Total
Shares |
56,192,553 |
|
|
| Total
Value |
$175,588,397 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -18.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
Former 10% Owner |
2004-07-02 |
0 |
2004-09-13 |
475,026 |
Premium* |
|
|
Idenix Pharmaceuticals Inc |
IDIX |
Director, 10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Director |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Former 10% Owner |
|
0 |
2013-03-11 |
2,790,479 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2012-02-01 |
0 |
2012-02-01 |
3,740 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
2012-06-05 |
0 |
2012-07-09 |
1,275,886 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,388,165 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
8,422,847 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
Director, 10% Owner |
2019-02-19 |
0 |
2023-06-01 |
0 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2021-07-12 |
3,882,485 |
Premium* |
|
|
Allovir Inc |
ALVR |
Director, 10% Owner |
2022-07-28 |
30,197 |
2022-07-28 |
16,674,766 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
10% Owner |
2020-09-21 |
0 |
2020-09-21 |
91,081 |
Premium* |
|
|
Oncorus, Inc. |
ONCR |
10% Owner |
|
0 |
2020-10-06 |
2,377,025 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRR |
Tcr2 Therapeutics Inc. |
Director |
– • • |
2023-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,529,946) |
0 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Director |
– • • |
2023-05-22 |
4 |
S |
$1.88 |
$131,920 |
I/I |
(70,170) |
304,001 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Director |
– • • |
2023-05-22 |
4 |
OE |
$0.74 |
$131,919 |
I/I |
178,269 |
374,171 |
0 |
- |
|
| ALVR |
Allovir Inc |
Director |
– • • |
2022-07-28 |
4 |
A |
$4.61 |
$15,000,000 |
I/I |
3,253,796 |
16,674,766 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-07-12 |
4 |
AS |
$33.58 |
$1,948,413 |
I/I |
(58,012) |
3,882,485 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-07-09 |
4 |
AS |
$33.06 |
$134,455 |
I/I |
(4,067) |
3,940,497 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-29 |
4 |
AS |
$33.29 |
$89,883 |
I/I |
(2,700) |
3,944,564 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-28 |
4 |
AS |
$34.06 |
$564,042 |
I/I |
(16,500) |
3,947,264 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-25 |
4 |
AS |
$33.51 |
$756,220 |
I/I |
(22,567) |
3,963,764 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-24 |
4 |
AS |
$33.53 |
$205,237 |
I/I |
(6,121) |
3,986,331 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-23 |
4 |
AS |
$32.98 |
$46,502 |
I/I |
(1,410) |
3,992,452 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-22 |
4 |
AS |
$33.36 |
$127,081 |
I/I |
(3,800) |
3,993,862 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-21 |
4 |
AS |
$33.80 |
$1,296,858 |
I/I |
(37,588) |
3,997,662 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-18 |
4 |
AS |
$33.46 |
$302,963 |
I/I |
(9,000) |
4,035,250 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-17 |
4 |
AS |
$33.78 |
$1,099,039 |
I/I |
(32,518) |
4,044,250 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-09 |
4 |
AS |
$34.42 |
$1,221,633 |
I/I |
(35,230) |
4,082,995 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-08 |
4 |
AS |
$32.80 |
$869,825 |
I/I |
(26,200) |
4,118,225 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-07 |
4 |
AS |
$30.74 |
$755,401 |
I/I |
(23,117) |
4,144,425 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-04 |
4 |
AS |
$30.80 |
$394,522 |
I/I |
(12,736) |
4,167,542 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-03 |
4 |
AS |
$31.92 |
$711,688 |
I/I |
(22,296) |
4,180,278 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-02 |
4 |
AS |
$31.83 |
$197,999 |
I/I |
(6,215) |
4,202,574 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-06-01 |
4 |
AS |
$32.50 |
$492,083 |
I/I |
(15,141) |
4,208,789 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-05-28 |
4 |
AS |
$32.67 |
$546,961 |
I/I |
(16,742) |
4,223,930 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-05-27 |
4 |
AS |
$32.81 |
$262,141 |
I/I |
(7,951) |
4,240,672 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
10% Owner |
– – • |
2021-05-26 |
4 |
AS |
$32.74 |
$787,399 |
I/I |
(24,036) |
4,248,623 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
